From Wikipedia, the free encyclopedia
Rituximab (trade names
Rituxan,
MabThera and
Zytux) is a
chimeric monoclonal antibody against the protein
CD20, which is primarily found on the surface of immune system
B cells.
Rituximab destroys B cells and is therefore used to treat diseases
which are characterized by excessive numbers of B cells, overactive B
cells, or dysfunctional B cells. This includes many
lymphomas,
leukemias,
transplant rejection, and
autoimmune disorders.
https://en.wikipedia.org/wiki/Rituximab
No comments:
Post a Comment